Centrus shares rose modestly by 2.0% following Q2 results that showed steady execution and growing backlog but lacked a clear catalyst to drive a stronger market response.
- Reported Q2 revenue of $176.1 million with gross profit of $49.9 million and operating income of $10.4 million.
- Adjusted net income was $38.7 million, translating to adjusted diluted EPS of $1.77.
- Backlog grew to $4.5 billion, with $3.7 billion from LEU and $0.8 billion from Technical Solutions segments, reflecting solid order momentum.
- Signed a $900 million DOE task order supporting commercial-scale production capacity expansion, marking a key transition from demonstration to commercial readiness.
- Completed HALEU production requirements under the DOE contract two weeks ahead of schedule, with near-term plans to commercialize existing HALEU cascade operations.
Community Discussion